July 2024
Three little-known stocks driving this veteran’s mega returns
Pengana’s James McDonald discusses his blockbuster year and the ASX-listed stocks he is backing into the new financial year.
- Joshua Peach
April 2024
Why picking ASX biotechs is mostly for the crazy brave
It’s a space with a reputation for rollercoaster returns and outlandish sales pitches, but some investors get lucky.
- Tom Richardson
May 2021
- Opinion
- China relations
How we should deal with China’s state-owned behemoths
Australia is uniquely exposed to Chinese investment, trade and companies owned by the Chinese government. The country needs to think about what kind of relationship it wants for the future.
- Adrian Blundell-Wignall
December 2020
There's never been a better time to mine coal in Siberia
As China blacklists coal shipments from Australia, a bunch of Australian millionaires and billionaires are ramping up their Siberian coking coal play.
- Peter Ker
November 2020
- Exclusive
- China
Telix boss says rising tensions with China are 'worrisome'
The head of the radiation oncology company said it was "worrisome" he had to weigh the escalating political tensions with Beijing when penning a recent $400 million deal with one of China's largest pharma companies.
- Carrie LaFrenz
June 2020
- Breaking
- Insider trading
Insider trading biotech boss released on good behaviour bond
The former CEO of biotech Sirtex Medical, Gilman Wong, faced up to 10 years in prison but was given a non-custodial sentence of 18 months and released on a three-year good behavior bond.
- Carrie LaFrenz
July 2019
Former Sirtex Medical CEO Gilman Wong pleads guilty to insider trading
The former CEO of the biotech sold more than a quarter of his holding a day after the company used its annual meeting to reaffirm its forecast of double-digit growth.
- Carrie LaFrenz
June 2019
Sirtex settlement leaves double-digit growth mystery
The class action against Sirtex over guidance provided in 2016 may have changed the way ASX companies provide profit guidance.
- James Thomson
Sirtex class action settled
A class action brought against Sirtex over a profit downgrade in 2016 has been settled two weeks into a Federal Court trial.
- James Thomson
September 2018
Ex-Sirtex Medical CEO Gilman Wong charged with insider trading
The corporate regulator has charged former chief executive of Sirtex Medical, Gilman Wong, with one count of insider trading.
- Updated
- Carrie LaFrenz
July 2018
Sirtex founder Bruce Gray returns to register amid takeover offer
Sirtex's combative founder has lodged his first substantial shareholder notice in five years.
- Updated
- Myriam Robin
June 2018
Sirtex Medical confident on Chinese deal closure
Sirtex Medical boss Andrew McLean is confident the $1.9 billion takeover deal penned with China's CDH Investments will not hit any regulatory hurdles.
- Updated
- Carrie LaFrenz
- Exclusive
Sirtex Medical board backs $1.9b Chinese offer
The board of Sirtex Medical has thrown its weight behind China's CDH Investments' $1.9b bid, dashing the hopes of rival bidder Varian Medical Systems.
- Updated
- Carrie LaFrenz
Sirtex Medical suitor CDH Investments is the 'KKR of China'
The Chinese private equity firm late to a bidding war for Sirtex Medical might be mysterious, but it is also serious.
- Updated
- Carrie LaFrenz
Integral Diagnostics chairman Helen Kurincic says the stakes are higher for women
When things go wrong for a company led by a woman there is a "forensic examination" of her skills, background and personal life, director Helen Kurincic says.
- Updated
- Carrie LaFrenz
May 2018
China's CDH Investments pitches winning formula for Sirtex
As Sirtex Medical's board tries to pit a big bid from a relatively unknown suitor against a smaller but safer offer from a $US10 billion trade player, the newcomer is ready to lift up its skirt.
- Updated
- Sarah Thompson, Anthony Macdonald and Julie-anne Sprague
Varian Medical Systems won't up its bid for Sirtex Medical
US giant Varian Medical Systems said it will not increase its takeover offer for target liver cancer treatment provider Sirtex Medical.
- Updated
- Carrie LaFrenz
Private equity firms keep investment bankers busy
The Australian market is proving to be a happy hunting ground for leading local and international PE firms.
- Updated
- Tony Boyd
Lazard helps inject life into Sirtex Medical takeover
Lazard Australia's financial advisory team has entered Sirtex Medical's dataroom on behalf of the firm's newest client.
- Updated
- Sarah Thompson, Anthony Macdonald and Julie-anne Sprague
More questions than answers as CDH stalks Sirtex Medical
There is nothing like a mystery Chinese bidder to spark an auction (back to) life.
- Updated
- Sarah Thompson, Anthony Macdonald and Joyce Moullakis